Loading clinical trials...
Loading clinical trials...
Impact on Anticoagulation Management When Activated Clotting Time is Combined With Heparin Concentration Monitoring in Cardiac Surgery: a Randomised Clinical Trial
Conditions
Interventions
Activated Clotting Time measurements combined with heparin concentration monitoring
Activated Clotting Time
Locations
1
Greece
AHEPA University Hospital, Aristotle University of Thessaloniki
Thessaloniki, Greece
Start Date
January 1, 2021
Primary Completion Date
December 31, 2022
Completion Date
February 20, 2023
Last Updated
July 14, 2023
NCT05669183
NCT07267013
NCT07212842
NCT06168539
NCT05426564
NCT03939273
Lead Sponsor
Aristotle University Of Thessaloniki
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions